Medical feed additives are various types of products used in animal nutrition to improve the nutritional content and quality of feed, or to improve the health and performance of animals. They help improve the nutritional content and quality of feed, resulting in higher productivity and disease prevention. The main types of medical feed additives are antioxidants, antibiotics, probiotics, prebiotics, enzymes, and amino acids. The antioxidants refer to the feed additives that are fed to the animals for nutrition. The different mixtures include supplements, concentrates, premixed feeds, and base mixes. The various classes include typing a, type b, and type c. These are used by different livestock, such as ruminants, poultry, swine, and aquaculture. The medical feed additives research report is one of a series of new reports from The Business Research Company that provides medical feed additives statistics, including medical feed additives industry global market size, regional shares, competitors with medical feed additives share, detailed medical feed additives segments, market trends and opportunities, and any further data you may need to thrive in the medical feed additives industry. This medical feed additives research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global medical feed additives market size will grow from $14.38 billion in 2022 to $15.6 billion in 2023 at a compound annual growth rate (CAGR) of 8.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global medical feed additives market size is expected to grow to $20.75 billion in 2027 at a CAGR of 7.4%. An increase in the prevalence of diseases among animals is driving the growth of the medicated feed additives market. According to estimates from a report by the Animal and Plant Health Agency, a total of 3289 new TB herd incidents were detected in England. A new herd incident is a case of bovine TB that occurs as a result of a herd or individual animal test performed in an officially TB-free (OTF) herd during the study period. Bovine tuberculosis is a chronic disease that usually affects animals such as cattle, but it can affect all mammals, causing illness, coughing, and eventual death. Moreover, according to the reports, the herd incidence rate in England for the 12 months to September 2020 was 9.4. The additives help prevent animals from diseases alongside increasing the nutrition level of the feed, thereby increasing demand for feed additives. The overuse and inappropriate use of antibiotics in medical feed additives impacts the health of individuals consuming animal meat or other related products. Moreover, the health of the animal consuming the feed may also be adversely affected by the antibiotics added to the feed as the excess additive reduces the natural immunity of the animal and increases the susceptibility of the livestock to infections. For instance, in July 2020, the Ministry of Agriculture and Rural Affairs in China, under Announcement No. 194, banned the production of commercial feed with medicated feed additives (excluding traditional Chinese medicine) for growth-promoting purposes. The negative effects of additives on human health caused by overuse of feed additives in animals will restrain the growth of the market. Companies in the medical feed additives market are introducing new feed medicated additives formed as a result of a combination of two or more medicated feed additives. More than 70% of manufacturers are now using more than one feed additive in animal feed to increase the efficiency of the product. For instance, Zoetis, a global health company, got approval for its Cyden and Lincomix combination feed additive from the FDA (Food and Drug Administration) and it is proposed to be used as a medicated feed additive for poultry. Also, the FDA-approved combination of Zoetis’ feed additives ACTOGAIN 45 (ractopamine hydrochloride) and ENGINE (ractopamine hydrochloride) produces more lean muscle and less fat while optimising feed efficiency. The medical feed additives market is regulated by government agencies that lay down regulations to be followed by all manufacturers of veterinary medicines. For instance, the Veterinary Medicines Regulations (VMR) 2013 make provision for the authorization, manufacturing, and classification of veterinary products, including medicated feed additives. Schedule 5 under EU guidelines covers medicated feeding stuff and specified feed additives, which specify guidance to both manufacturers and suppliers of veterinary medicines for incorporating them into animal feed, as well as to veterinary surgeons, animal keepers, and other members involved in the use of veterinary medicines and SFAs(Specified Feed Additives)in animal feeding stuff. In June 2022, Cargill, Inc., a US-based food and agriculture company, acquired DelaconBiotechnik GmbH for an undisclosed amount. The acquisition combines Delacon's innovative know-how and market experience with Cargill's extensive global network and deep expertise in animal nutrition technologies. Phytogenic feed additives are a category that utilizes a variety of herbs, plants, and their extracts, such as essential oils, to enhance livestock and aquaculture performance, promote animal health, and enhance Cargill’s feed additive research capabilities. DelaconBiotechnik GmbH is an Austria-based feed additive company pioneering in plant-based phytogenic additives to improve livestock and aquaculture performance and promote animal health. Major players in the medical feed additives market are Zoetis Inc., Cargill, Incorporated, CHS Inc., Purina Animal Nutrition, Archer Daniels Midland Company, Adisseo France Sas, Alltech Inc., Hipro Animal Nutrition, BASF SE, Biostadt India Limited. North America was the largest region in the medical feed additives market in 2022. Asia-Pacific was the second-largest region in the global medical feed additives market. The regions covered in the global medical feed additives report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the medical feed additives market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, and USA. The medical feed additives market consists of sales of digestibility enhancers, coccidiostats and histomonostats, antimicrobials, and growth hormones. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical feed additives market is segmented - 1) By Type: Antioxidants, Antibiotics, Probiotics And Prebiotics, Enzymes, Amino Acids 2) By Livestock: Ruminants, Poultry, Swine, Aquaculture 3) By Mixture Type: Supplements, Concentrates, Premix Feeds, Base Mixes 4) By Class type: Type A, Type B, Type C

Veterinary diagnostic equipment refers to devices and instruments mainly used by veterinary practitioners in determining and identifying various disorders in animals by using various diagnostic equipment such as clinical thermometers, diagnostic lights, X-ray equipment, and certain diagnostic test kits to detect the cause of disease and determine the treatment schedule for animals. The main types of veterinary diagnostic equipment are hematology, immunodiagnostics, clinical chemistry, and molecular testing. Hematology refers to the study of the prognosis, causes, and treatment of diseases related to the blood. These are used for livestock like cattle and domestic pets. Veterinary diagnostic equipment is used in hospitals and clinics, reference laboratories, universities, research centers, and point-of-care/in-house testing. The veterinary diagnostic equipment research report is one of a series of new reports from The Business Research Company that provides veterinary diagnostic equipment statistics, including veterinary diagnostic equipment industry global market size, regional shares, competitors with veterinary diagnostic equipment share, detailed veterinary diagnostic equipment segments, market trends and opportunities, and any further data you may need to thrive in the veterinary diagnostic equipment industry. This veterinary diagnostic equipment research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global veterinary diagnostic equipment market size will grow from $0.94 billion in 2022 to $1.01 billion in 2023 at a compound annual growth rate (CAGR) of 7.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global veterinary diagnostic equipment market size is expected to grow from $1.31 billion in 2027 at a CAGR of 6.7%. An increase in the prevalence rate of diseases among animals serves as one of the major drivers of the veterinary diagnostic equipment market. Due to the increase in the incidence of diseases in livestock and pets, the demand for enhanced diagnostic equipment increases. For instance, according to the Banfield Pet Hospital's 2020 Veterinary Emerging Topics (VET) Report, more than 50% of the dogs at 1,000 hospitals in 2019 were overweight or obese. Overweight pets are more likely to suffer from joint disease, respiratory disease, and other preventable conditions. The increase in the prevalence rate of diseases in animals increases demand for diagnostic equipment, driving the veterinary diagnostic equipment market. Veterinary diagnostic equipment is highly expensive. The cost of equipment will be a significant expense for a veterinary clinic or hospital. To run a test centre with blood testing machines, physiological monitors such as ECGs, anaesthetic monitors, etc., and diagnostic imaging techniques such as x-rays, ultrasound, and MRI scanners, is highly capital intensive. Some kinds of veterinary diagnostic equipment may be available on a budget, but with less precise diagnoses and thus less efficient treatments with less beneficial results. The high cost of equipment hinders the growth of the veterinary diagnostic equipment market. Veterinary diagnostic equipment manufacturers are introducing advanced technologies such as advanced blood microsampling techniques to enable enhanced precision, patient-centered specimen collection, and diagnosis of diseases in animals. Blood microsampling is a technique that allows the participants to draw blood samples from their livestock and companion animals with ease. The samples are then forwarded to labs for further diagnosis. This technique is an extension of dry blood sampling, which is a method of collecting blood. For instance, Neoteryx launched the '3Rs-compliant Mitra' microsampling device that works on the principle of micro sampling. The device uses Neoteryx's trademark Volumetric Absorptive Micro Sampling (VAMS) technology to facilitate more convenient and accurate remote sampling. Other companies investing in the trend of microsampling include Diatron with its Diatron Aquila hematologyanalyzer. The US Food and Drug Administration (FDA) defines regulations for veterinary diagnosis equipment and can take appropriate action if veterinary equipment is found misbranded or adulterated. The conditions for misbranding diagnostic equipment are listed under title 21 and set by the Food and Drugs Administration (FDA). For instance, as per the regulations under title 21, U.S code 352(f)(1), any veterinary medical equipment is considered misbranded if the labeling on the equipment is indefinite or unclear. Whereas, 21 U.S.C. 352(j) states that veterinary medical equipment is considered misbranded if it is dangerous to the animal even when it is used in the manner recommended, or suggested as per the label. In September 2021, Mindray, a company operating in veterinary imaging equipment based in China, acquired HyTest Invest Oy and its subsidiaries for an undisclosed amount. With this acquisition, HyTest company enables Mindray to have top-notch raw material R&D and innovation capabilities and also helps in investing in R&D as well as strengthening and improving its competitive edge. Hytest is a company operating in veterinary diagnostic equipment based in Finland. Major players in the Veterinary diagnostic equipment market are IDEXX Laboratories, ABAXIS, HESKA Corporation, Zoetis, Virbac, Mindray Medical International Ltd., Neogen Corporation, QIAGEN N.V., Agfa Healthcare, and Toshiba. North America was the largest region in the veterinary diagnostic equipment market in 2022. Asia-Pacific was the second-largest region in the global veterinary diagnostic equipment market. The regions covered in the global veterinary diagnostic equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the veterinary diagnostic equipment market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, and USA. The veterinary diagnostic equipment market consists of sales of testing reagents and kits, blood pressure monitoring devices, stethoscopes, and electrocardiograms. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global veterinary diagnostic equipment market is segmented - 1) By Product: Hematology, Immunodiagnostics, Clinical Chemistry, Molecular Testing 2) By End Users: Hospitals And Clinics, Reference Laboratories, Universities/Research Centers, Point-Of-Care/In-House Testing 3) By Animal: Livestock Cattle, Domestic Pets

Nutritional feed additives various types of products used in animal nutrition to improve the nutritional content and quality of feed, or to improve the health and performance of animals. They help improve the nutritional content and quality of feed, resulting in higher productivity and disease prevention. The main additive types of nutritional feed additives are antibiotics, vitamins, antioxidants, amino acids, enzymes, mycotoxin detoxifiers, prebiotics, probiotics, flavours and sweeteners, pigments, binders, and minerals. Antibiotics are medications that aid in the treatment of bacterial illnesses. They accomplish this by either killing the bacteria or preventing them from replicating or reproducing. The nutritional feed additives are available in various forms, such as dry, liquid, and other forms that are used on ruminants, poultry, swine, and aquatic livestock. The additives are distributed through direct, indirect channels; hypermarkets and supermarkets; specialty stores, and online retail channels. The nutritional feed additives research report is one of a series of new reports from The Business Research Company that provides nutritional feed additives statistics, including nutritional feed additives industry global market size, regional shares, competitors with nutritional feed additives share, detailed nutritional feed additives segments, market trends and opportunities, and any further data you may need to thrive in the nutritional feed additives industry. This nutritional feed additives research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global nutritional feed additives market size will grow from $3.89 billion in 2022 to $4.19 billion in 2023 at a compound annual growth rate (CAGR) of 7.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global nutritional feed additives market size is expected to grow to $5.41 billion in 2027 at a CAGR of 6.6%. The rise in consumption of meat products is one of the driving factors for the nutrition feed additives market. Due to high meat consumption, the concern for high-quality meat is also increasing. Thus, to deliver high-quality meat, add-on nutrition feed additives are fed to the animals so that they have good digestion to build on more muscle and weight. This increases the yield and productivity and, hence, the demand for nutritional feed additives. Currently, meat and poultry consumption in the US is more than 100 billion pounds every year. The stringent regulations act as one of the major restraining factors for the nutrition feed additives market. There are many mandatory documents, required to be approved before approving the nutritional feed, which delays the approval process. Therefore, the product launch and expansion of companies in new regional markets will be delayed. For instance, China's AQSIQ (Administration for Quality Supervision and Inspection and Quarantine) issued 2 reports for the nutrition feed additive companies to get their products registered and approved by the concerned Chinese authorities before selling them in the Chinese market. The report also made it compulsory for all the exporters to have a licence to sell their nutrition feed additive products in the Chinese market, which delays the nutritional feed additives from reaching the stores. Feed additives manufacturers are investing in the R&D of organic feed additives as there is a growing demand for organic and natural feed products in the nutritional feed additives market. When compared to synthetic nutrition feed additives, organic feed additives have fewer side effects and also improve yield. Therefore, poultry farmers are switching to herbal nutrition feed additives. For instance, Agpulse Organics has come up with its herbal animal feed additive 'Govahnika-Biosheera', which is fed to cattle to increase milk productivity while maintaining the health of cattle and quality of milk. In September 2020, Adisseo acquired Framelco G for an undisclosed amount. With this acquisition, the company will enhance the growth of specialties to become the world leader in the field of specialty feed ingredients in animal nutrition. Framelco G is a family-owned multinational company that develops and manufactures feed additives and drinking water solutions for livestock production. Major players in the nutritional feed additives market are BASF SE, Cargill, Archer Daniels Midland Company, Evonik Industries AG, Nutreco N.V., Kemin Industries Inc., Adisseo, Alltech, Phibro Animal Health Corporation, and DowDuPont. North America was the largest region in the nutritional feed additives market in 2022. Asia-Pacific was the second-largest region in the global nutritional feed additives market. The regions covered in the global nutritional feed additives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the nutritional feed additives market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The nutritional feed additives market consists of sales of digestibility enhancers, coccidiostats and histomonostats, antimicrobials, and growth hormones. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global nutritional feed additives market is segmented - 1) By Distribution Channel: Direct, Indirect, Hypermarket/Supermarket, Specialty Stores, Online Retail 2) By Livestock: Ruminants, Poultry, Swine, Aquatic 3) By Additive Type: Antibiotics, Vitamins, Antioxidants, Amino Acids, Enzymes, Mycotoxin Detoxifiers, Prebiotics, Probiotics, Flavors And Sweeteners, Pigments, Binders, Minerals 4) By Form: Dry, Liquid, Other Forms

Animal growth promoters and performance enhancers refer to the substances that are added to feeds as supplements or injections to increase feed utilization and growth in farm animals, as well as veterinary medicinal products that are administered to healthy animals in order to favourably influence the yield, quality, and/or growth of animal products. The main types of animal growth promoters and performance enhancers are antibiotic growth promoters and non-antibiotic growth promoters. Antibiotic growth promoters refer to the promoters that will enhance the health of the animal and increase productivity. These include natural chemicals such as microbial products, prebiotics, and probiotics; yeast products; enzymes and herbs; oils; and spices. The different types of animals that use animal growth promoters and performance enhancers include poultry, swine, livestock, aquaculture, and other animals. The animal growth promoters and performance enhancers research report is one of a series of new reports from The Business Research Company that provides animal growth promoters and performance enhancers statistics, including animal growth promoters and performance enhancers industry global market size, regional shares, competitors with animal growth promoters and performance enhancers share, detailed animal growth promoters and performance enhancers segments, market trends and opportunities, and any further data you may need to thrive in the animal growth promoters and performance enhancers industry. This animal growth promoters and performance enhancers research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global animal growth promoters and performance enhancers market size will grow from $13.73 billion in 2022 to $14.65 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global animal growth promoters and performance enhancers market size is expected to grow to $18.92 billion in 2027 at a CAGR of 6.6%. The growing demand for meat is a significant factor that will drive the market for animal growth promoters and performance enhancers. Animal growth promoters make the animal accumulate fat and weight, resulting in more meat production and a more expensive animal. Meat is a major protein source for many people around the world. According to a study by FAO, the production of meat has doubled in the last 30 years and increased four-fold since the mid-1960s. The production and consumption of meat are expected to continue to grow. By 2050, global meat consumption is projected to reach between 460 million and 570 million tons. This is expected to drive the animal growth promoters and performance enhancers market. Strict rules set by the US and European governments on the use of animal growth promoters and performance enhancers are restricting the animal growth promoter and performance enhancers market. For instance, Zoetis, the largest producer of animal medicines, is banned from selling antibiotics that promote faster growth in animals in the US and Europe. The US FDA has implemented a regulation that bans the use of antibiotics as feed supplements to help livestock and poultry grow faster. These regulations are expected to negatively impact the growth of the market. Companies in the market are increasingly investing in phytogenics for higher efficiency of growth promoters through natural means. Phytogenics, sometimes also referred to as botanicals or phytobiotics, are plant-based feed additives utilised in animal nutrition. They are derived from herbs, spices, and extracts. Phytochemicals can be used in solid, dried, and ground form or as extracts, and can also be classified as essential oils and oleoresins depending on the process used to derive the active ingredients. The use of phytogenics promotes increased feed intake, improved gut function, prevention of diarrhea, and antimicrobial and antioxidative effects in livestock. Companies such as Delacon, Cargill, and BIOMIN have invested in phytogenics. In June 2020, Elanco acquired Bayer Animal Health for $7.6 billion. This acquisition is expected to help Elanco expand its product profile and reach for medicines for pets and livestock. Bayer Animal Health is a division of Bayer HealthCare. Major players in the animal growth promoters and performance enhancers market are Merck Animal Health, Cargill, Royal DSM N.V., Vetoquinol S.A., Bupo Animal Health, Elanco Animal Health Inc., Alltech, Bayer Animal Health, Zoetis, and Bioniche Life Sciences. North America was the largest region in the animal growth promoters and performance enhancers market in 2022. Asia-Pacific was the second-largest region in the global animal growth promoters and performance enhancers market. The regions covered in the global animal growth promoters and performance enhancers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the animal growth promoters and performance enhancers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The animal growth promoters and performance enhancers market consists of sales of growth hormone medications, anabolic implants, bovine somatotropin, ß-agonists and probiotics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global animal growth promoters and performance enhancers market is segmented - 1) By Type: Antibiotic Growth Promoters, Non-Antibiotic Growth Promoters 2) By Animal Type: Poultry, Swine, Livestock, Aquaculture, Other Animals 3) By Nature of Chemicals: Microbial Products, Prebiotics And Probiotics, Yeast Products, Enzymes/Herbs, Oils And Spices

Animal medicines refer to a collective term for drugs and therapies, including veterinary vaccines, veterinary antibiotics, and other veterinary pharmaceuticals, that are used to treat animal diseases to improve animals’ performance and health by identifying disease symptoms and drugs for the cure of illness. The main types of animal medicines are veterinary pharmaceuticals and feed additives, which are used for livestock and companion animals. Veterinary pharmaceuticals refer to animal medicine that is given to animals for treating diseases. Animal medicine is used by veterinary hospitals, pharmacies, drug stores, and veterinary clinics. The animal medicine research report is one of a series of new reports from The Business Research Company that provides animal medicine statistics, including animal medicine industry global market size, regional shares, competitors with animal medicine shares, detailed animal medicine segments, market trends and opportunities, and any further data you may need to thrive in the animal medicine industry. This animal medicine research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global animal medicine market grew from $46.91 billion in 2022 to $50.47 billion in 2023 at a compound annual growth rate (CAGR) of 7.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, and affecting many markets across the globe. The animal medicine market is expected to grow from $65.12 billion in 2027 at a CAGR of 6.6%. The increasing penetration of pet insurance is expected to drive the animal medicine market. Globally, the pet insurance market is largely untapped with extremely low penetration rates, providing a large market opportunity. In developed economies such as the USA, the pet insurance penetration rate is around 1%, although in Western European countries such as the UK, the penetration rate is around 20%. During the forecast period, the pet insurance market in the USA is expected to grow by $2 billion in 2022, at a compound annual growth rate of 14%, mainly driven by the increasing consumer awareness and rising disposable income of companion animal owners. Increasing penetration of pet insurance will increase the number of visits at veterinary clinics supporting the use of animal medicine in the treatment of different diseases The outbreak of COVID-19 disease (COVID-19) has acted as a massive restraint on the animal medicine market in 2020 as supply chains were disrupted due to trade restrictions and consumption declined due to lockdowns imposed by governments globally. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China, and has spread globally, including Western Europe, North America, and Asia. Steps by national governments to contain the transmission have resulted in a decline in economic activity with countries entering a state of "lock down" and the outbreak hurting businesses throughout 2020 and into 2021. However, it is expected that the animal medicine market will recover from the shock over the forecast period as it is a "black swan" event and not related to ongoing or fundamental weaknesses in the market or the global economy. Nanotechnology is increasingly gaining traction in the animal medicine market as a substitute for veterinary antibiotics. Nanotechnology is the study of controlling matter on an atomic and molecular scale. In the animal medicine industry, nanotechnology is used to improve diagnosis, treatment, animal growth promotion, and production. Nanoparticles are mainly used as alternative antimicrobial agents to reduce the use of antibiotics and improve the detection of pathogenic bacteria. They are also used as drug delivery agents for new drugs and vaccine candidates to improve their characteristics and performance and to reduce drug resistance in animal organisms. Major companies in the animal medicine market include Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co, Evonik Industries AG, Patterson Companies Inc., Ceva Animal Health LLC – Biomune, Phirbo Animal Health, Dechra Pharmaceuticals, Virbac Group, and Vetoquinol S.A. North America was the largest region in animal medicine market in 2022. Asia-Pacific was the second-largest region in the animal medicine market. The regions covered in the animal medicine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the animal medicine market include Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The animal medicine market consists of sales of procuring drugs to shield against external parasites like fleas, ticks, and heartworms (intestinal parasites). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global animal medicine market is segmented - 1) By Type: Veterinary Pharmaceuticals, Feed Additives 2) By Type of Animal: Livestock, Companion Animals 3) By End-Use: Veterinary Hospitals, Pharmacies And Drug Stores, Veterinary Clinics Subsegments Covered: Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Veterinary Pharmaceuticals, Medical Feed Additives, Nutritional Feed Additives

A milking machine is a piece of equipment that consists of a suction apparatus that takes milk from the cows. They are used to extract milk from cows. The main product types of milking machines are fully automatic and semi-automatic. Fully automatic refers to a device that has controls to enable it to perform a task without constantly operating by a person. The livestock is the cow, sheep, goat, buffalo, and other livestock. The various applications involved are micro-dairy farms, macro dairy farms, and other applications. The milking machines market research report is one of a series of new reports from The Business Research Company that provides milking machines market statistics, including milking machines industry global market size, regional shares, competitors with a milking machines market share, detailed milking machines market segments, market trends and opportunities, and any further data you may need to thrive in the milking machines industry. This milking machines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global milking machines market size will grow from $3.88 billion in 2022 to $4.23 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global milking machines market size is expected to grow to $5.76 billion in 2027 at a CAGR of 8.0%. An increase in the rearing of dairy cattle is expected to drive the demand for the milking machines market. For instance, in October 2021, according to Central Statistics Office, Ireland, in 2020, there were 1,567,700 dairy cows, a 4.2% increase from 2019. Further, in May 2021, according to data from the US Department of Agriculture Foreign Agriculture Service, the number of dairy cows globally increased from about 136 million heads in 2019 to 137 million heads in 2020. (USDA FAS). It is predicted that in 2021, there would be more than 138 million heads of the animals in question. Therefore, the growth in the dairy cattle population across the globe led to increasing in milking production, which in turn propelled the revenues generated for the milking machinery market. The robotic milking machines have created immense demand in the milking machinery market. More dairy farmers are looking to robotic-milking systems as a result of the difficulty in finding a dependable workforce or being able to afford labor costs. For instance, in May 2021, Fullwood Packo, a UK-based manufacturer of milking machines, launched the new robotic technology M2erlin Meridian. Given that it is well acknowledged that cow comfort is essential to high-quality production, it was designed with cows in mind. Combining the stability and routine of traditional milking with the technology and time benefits of robotics through the batch milking idea maximises both worlds. Additionally, unlike with free-choice milking, it enables the installation of robots without fully redesigning the cow habitat. In July 2020, DeLaval, a Swedish-based company that produces equipment for the dairy farmer, acquired Milkrite InterPuls for approximately $233.58 million. The acquisition is expected to help DeLaval to increase its investments in future dairy solutions and services and the agreement is subjected to clearance from the relevant antitrust authorities. Milkrite InterPuls is a global company providing dairy intelligence products and services for milking equipment that are innovative, durable, and competitive in price. Major players in the milking machines market are Lely Holding S.a.r.l, GEA Group, DeLaval Inc., Fullwood Ltd., BouMatic Robotics B.V, S. A. Christensen & Co., AMS-Galaxy USA, Bon-Matic, Universal, and Afimilk Ltd. The Asia-Pacific was the largest region in the milking machines market in 2022. North America was the second largest region in the global milking machines market. The regions covered in the global milking machines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the milking machines market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The milking machine market consists of sales of herringbone milking parlour, rotary milking parlour, swingover miking parlour, and bucket milking machine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global milking machines market is segmented - 1) By Product Type: Fully Automatic, Semi-Automatic 2) By Livestock: Cow, Sheep, Goat, Buffalo, Other Livestocks 3) By Application: Micro Dairy Farms, Macro Dairy Farms, Other Applications

Veterinary pharmaceuticals are a class of drugs that are pharmacologically active and used to control, prevent, and treat diseases in animals. They have an effect when administered to animals and are rapidly broken down into active ingredients due to small intestine metabolism. The main types of veterinary pharmaceuticals include veterinary vaccines, veterinary antibiotics, veterinary parasiticides, and other types. Veterinary vaccines provide protection against one or more diseases, which can lower the severity or prevent certain diseases entirely. The routes of administration include oral and other routes of administration for animal types, including companion animals and livestock animals. The vaccines include inactivated vaccines, attenuated vaccines, and recombinant vaccines. The veterinary pharmaceuticals research report is one of a series of new reports from The Business Research Company that provides veterinary pharmaceuticals statistics, including veterinary pharmaceuticals industry global market size, regional shares, competitors with veterinary pharmaceuticals share, detailed veterinary pharmaceuticals segments, market trends and opportunities, and any further data you may need to thrive in the veterinary pharmaceuticals industry. This veterinary pharmaceuticals research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global veterinary pharmaceuticals market size will grow from $28.43 billion in 2022 to $30.2 billion in 2023 at a compound annual growth rate (CAGR) of 6.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global veterinary pharmaceuticals market size is expected to grow from $37.12 billion in 2027 at a CAGR of 5.3%. The increase in the prevalence rate of diseases among animals serves as one of the major drivers for the veterinary pharmaceuticals market. The increase in the incidence of diseases in livestock and companion animals will require medicines to treat the animals for the diseases. For instance, according to the Banfield State of Pet Health Report, the prevalence of diabetes in dogs has increased by 79.7% from 13.1 cases per 10,000 to 23.6 cases whereas the prevalence rate increased by 18% in cats. The increase in the prevalence rate of diseases among animals results in an increased demand for veterinary pharmaceuticals. The veterinary pharmaceuticals market is being restrained by a lack of awareness about animal healthcare. According to the Animal Welfare Act 2006, proper healthcare means the pet should have regular vaccinations, a suitable diet, protection from pain and suffering, suffering and should be free from any kind of disease. According to the PDSA Animal Wellbeing (PAW) UK report, only 38% of people in the UK are aware of this legislation which shows a very less proportion of the population is aware of animal healthcare and acts as a major restraint for the market. The rise of generic drugs for animal care is being seen as the latest trend in the veterinary pharmaceuticals market. The economical nature of generic drugs enables pet lovers to take care of their pets efficiently. The FDA has approved 22 generic animal drugs for cats and dogs, which has increased the adoption of generic drugs by veterinarians. According to a survey conducted on 520 veterinarians by Brakke and Trone Brand Energy Inc., around 80% of the veterinarians confirmed that they are using generic drugs to save the pet owners’ money. However, the lower margin of profit given by generic drug manufacturers compared with the heavy margins of branded drugs needs to be looked into by veterinarians. The veterinary pharmaceuticals market is regulated by government agencies such as European Medicines Agency (EMA), USFDA (the US Food and Drug Administration), and others. For instance, the EU agencies require 6 to 12 months to approve veterinary medicinal products. Moreover, it requires all parts of the registration dossier to be submitted together, unlike the US-FDA, which accepts phased submissions. The US-FDA assesses each technical section for 6 months which may be extended to another 6 month cycle if questions or concerns are raised. However, the technical sections’ assessment is done simultaneously, and therefore, the manufacturers should identify the time-consuming steps and plan the work accordingly and estimate the date of approval. Also, the license validity and renewal of the application in the EU region is very difficult upon the existing regulatory policies. Therefore, the manufacturers of veterinary pharmaceuticals should plan well, communicate effectively to minimize the costs and reduce timelines. Major players in the veterinary pharmaceuticals market are Merck & Co. Inc., Zoetis Inc., Eli Lilly and Company, Bayer AG, Boehringer Ingelheim GmbH, Perrigo Company PLC., Virbac SA, Dechra Pharmaceuticals PLC., CevaSanteAnimale, and Aratana Therapeutics. North America was the largest region in the veterinary pharmaceuticals market in 2022. Asia-Pacific was the second-largest region in the global veterinary pharmaceuticals market. The regions covered in the global veterinary pharmaceuticals report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the veterinary pharmaceuticals market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The veterinary pharmaceuticals market consists of sales of biological drugs, biosimilars, monoclonal antibodies, sedatives, and antihistaminic. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global veterinary pharmaceuticals market is segmented - 1) By Type: Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Types 2) By End User: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores 3) By Route of Administration: Oral, Other Routes Of Administration 4) By Animal Type: Companion Animals, Livestock Animals 5) By Vaccines: Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines

Feed premix refers to a mixture of one or more feed additives that are included in the diet of livestock animals and are not intended for direct consumption. Premix includes vitamins, trace minerals, medicaments, feed supplements, and diluents as its constituents. It's a value-added solution for feeds with long-term quality and safety. The main types of feed premix are amino acids, antioxidants, antibiotics, vitamins, minerals and others. The amino acids feed premix contains L-lysine, DL-methionine, and L-threonine which improves the synthetic efficiency of protein. The availability of those components permits a user to anticipate an increase in protein synthesis efficiency. The feed premix are available in two form namely dry and liquid and are used by livestock such as ruminants, swine, aquatic animals, poultry and pets. The feed premix market research report is one of a series of new reports from The Business Research Company that provides feed premix market statistics, including feed premix industry global market size, regional shares, competitors with a feed premix market share, detailed feed premix market segments, market trends and opportunities, and any further data you may need to thrive in the feed premix industry. This feed premix market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global feed premix market size grew from $19.2 billion in 2022 to $20.63 billion in 2023 at a compound annual growth rate (CAGR) of 7.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The feed premix market size is expected to grow to $30.12 billion in 2027 at a CAGR of 9.9%. The increase in the demand and consumption of livestock-based products is expected to propel the growth of the feed premix market. Livestock-based products comprise eggs, dairy products, and meat products. Adding feed premix to the livestock's diet helps in providing sufficient vitamins and minerals and enhances nutrition and better production of livestock-based products such as milk. An increase in the adoption and consumption of dairy and meat products is increasing the sales of livestock-based products which is driving the demand for feed premix. For instance, according to the U.S. Department of Agriculture (USDA) data, dairy consumption in America, in 2020, was around 655 pounds of dairy in milk, yogurt, cheese, butter, ice cream, and other wholesome and nutritious dairy foods, which is an increase of 3 pounds per person from 2019. Therefore, an increase in the demand and consumption of livestock-based products will drive the growth of the feed premix market. The development of a new feed ingredient is a key trend gaining popularity in the feed premix market. Advancement in the properties of feed ingredients will lead to improved properties of feed premixes which will benefit the consuming livestock. These new feed ingredients provide additional benefits such as improving health and maximizing production. For instance, in December 2021, BASF, a Germany-based chemical company, developed Natupulse TS, a revolutionary feed enzyme to release priceless nutrients. A non-starch polysaccharide (NSP) enzyme is Natupulse® TS. It hydrolyzes ß-mannans into smaller components, such as manno-oligosaccharides, as an endo-1,4-ß-D-mannanase (MOS). When ß-mannanase is added to the feed, the digesta viscosity is reduced, the feed's digestibility is increased, and a more sustainable output is ensured. In October 2020, Royal DSM, a Dutch company involved in the fields of health, nutrition, and materials acquired Erber Group for USD 1.04 billion. This acquisition is expected to strengthen DSM's experience and reputation as a leading provider of nutrition solutions for animals and will also help in reducing emissions, feed utilization efficiency, and enhancing water and land utilization. Erber Group is an Austrian company involved in the animal nutrition and health business. Major players in the feed premix market are Advanced Animal Nutrition Pty Ltd., Archer Daniels Midland Company, BASF SE, BEC Feed Solutions Pvt Ltd., Cargill Incorporated, Danish Agro Group, Dansk Landbrugs Grovvareselskab, De Heus Voeders BV, Phibro Animal Health Corporation, ForFramers BV, Godrej Agrovet Limited, Invivo NSA, Koninklijke Coöperatie Agrifirm UA, Koninklijke DSM, Land O'Lakes Inc., Nutreco NV, AB Agri Ltd., Agrofeed Ltd., Avitech Nutrition Pvt Ltd., DSM Austria GmbH (Biomin), Beijing Da Bei Nong Science and Technology Group Co Ltd (DBN Group), Burkmann Industries Inc., Purina Animal Nutrition LLC and Hi-Nutrients International Limited. Asia-Pacific was the largest region in the feed premix market in 2022. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the feed premix market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the feed premix market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The feed premix market consists of sales nucleotides, trace elements, and other functional ingredients. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global feed premix market is segmented - 1) By Type: Amino Acids, Antioxidants, Antibiotics, Vitamins, Minerals, Other Types 2) By Form: Dry, Liquid 3) By Livestock: Ruminants, Swine, Aquatic Animals, Poultry, Pets